Literature DB >> 33031741

Defining and Manipulating B Cell Immunodominance Hierarchies to Elicit Broadly Neutralizing Antibody Responses against Influenza Virus.

Assaf Amitai1, Maya Sangesland2, Ralston M Barnes3, Daniel Rohrer3, Nils Lonberg3, Daniel Lingwood4, Arup K Chakraborty5.   

Abstract

The antibody repertoire possesses near-limitless diversity, enabling the adaptive immune system to accommodate essentially any antigen. However, this diversity explores the antigenic space unequally, allowing some pathogens like influenza virus to impose complex immunodominance hierarchies that distract antibody responses away from key sites of virus vulnerability. We developed a computational model of affinity maturation to map the patterns of immunodominance that evolve upon immunization with natural and engineered displays of hemagglutinin (HA), the influenza vaccine antigen. Based on this knowledge, we designed immunization protocols that subvert immune distraction and focus serum antibody responses upon a functionally conserved, but immunologically recessive, target of human broadly neutralizing antibodies. We tested in silico predictions by vaccinating transgenic mice in which antibody diversity was humanized to mirror clinically relevant humoral output. Collectively, our results demonstrate that complex patterns in antibody immunogenicity can be rationally defined and then manipulated to elicit engineered immunity.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B cell; affinity maturation; antibody targeting; germinal center; immunodominance; in silico; influenza virus; in vivo; universal; vaccine

Mesh:

Substances:

Year:  2020        PMID: 33031741      PMCID: PMC7746579          DOI: 10.1016/j.cels.2020.09.005

Source DB:  PubMed          Journal:  Cell Syst        ISSN: 2405-4712            Impact factor:   10.304


  87 in total

1.  H3-rules: identification of CDR-H3 structures in antibodies.

Authors:  H Shirai; A Kidera; H Nakamura
Journal:  FEBS Lett       Date:  1999-07-16       Impact factor: 4.124

2.  Visualizing antibody affinity maturation in germinal centers.

Authors:  Jeroen M J Tas; Luka Mesin; Giulia Pasqual; Sasha Targ; Johanne T Jacobsen; Yasuko M Mano; Casie S Chen; Jean-Claude Weill; Claude-Agnès Reynaud; Edward P Browne; Michael Meyer-Hermann; Gabriel D Victora
Journal:  Science       Date:  2016-02-18       Impact factor: 47.728

Review 3.  Do Memory B Cells Form Secondary Germinal Centers? Yes and No.

Authors:  Mark J Shlomchik
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-01-02       Impact factor: 10.005

4.  Simulation of B cell affinity maturation explains enhanced antibody cross-reactivity induced by the polyvalent malaria vaccine AMA1.

Authors:  Sidhartha Chaudhury; Jaques Reifman; Anders Wallqvist
Journal:  J Immunol       Date:  2014-07-30       Impact factor: 5.422

5.  Germline-Encoded Affinity for Cognate Antigen Enables Vaccine Amplification of a Human Broadly Neutralizing Response against Influenza Virus.

Authors:  Maya Sangesland; Larance Ronsard; Samuel W Kazer; Julia Bals; Seyhan Boyoglu-Barnum; Ashraf S Yousif; Ralston Barnes; Jared Feldman; Maricel Quirindongo-Crespo; Patrick M McTamney; Daniel Rohrer; Nils Lonberg; Bryce Chackerian; Barney S Graham; Masaru Kanekiyo; Alex K Shalek; Daniel Lingwood
Journal:  Immunity       Date:  2019-09-25       Impact factor: 31.745

6.  A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases.

Authors:  Emily J Erbelding; Diane J Post; Erik J Stemmy; Paul C Roberts; Alison Deckhut Augustine; Stacy Ferguson; Catharine I Paules; Barney S Graham; Anthony S Fauci
Journal:  J Infect Dis       Date:  2018-07-02       Impact factor: 5.226

7.  Effective replication of human influenza viruses in mice lacking a major alpha2,6 sialyltransferase.

Authors:  Laurel Glaser; Gina Conenello; James Paulson; Peter Palese
Journal:  Virus Res       Date:  2007-02-20       Impact factor: 3.303

8.  Simulation and Theory of Antibody Binding to Crowded Antigen-Covered Surfaces.

Authors:  Cristiano De Michele; Paolo De Los Rios; Giuseppe Foffi; Francesco Piazza
Journal:  PLoS Comput Biol       Date:  2016-03-11       Impact factor: 4.475

9.  Persisting fetal clonotypes influence the structure and overlap of adult human T cell receptor repertoires.

Authors:  Mikhail V Pogorelyy; Yuval Elhanati; Quentin Marcou; Anastasiia L Sycheva; Ekaterina A Komech; Vadim I Nazarov; Olga V Britanova; Dmitriy M Chudakov; Ilgar Z Mamedov; Yury B Lebedev; Thierry Mora; Aleksandra M Walczak
Journal:  PLoS Comput Biol       Date:  2017-07-06       Impact factor: 4.475

10.  Lamprey VLRB response to influenza virus supports universal rules of immunogenicity and antigenicity.

Authors:  Meghan O Altman; Jack R Bennink; Jonathan W Yewdell; Brantley R Herrin
Journal:  Elife       Date:  2015-08-07       Impact factor: 8.140

View more
  14 in total

1.  Allelic polymorphism controls autoreactivity and vaccine elicitation of human broadly neutralizing antibodies against influenza virus.

Authors:  Maya Sangesland; Alba Torrents de la Peña; Seyhan Boyoglu-Barnum; Larance Ronsard; Faez Amokrane Nait Mohamed; Thalia Bracamonte Moreno; Ralston M Barnes; Daniel Rohrer; Nils Lonberg; Musie Ghebremichael; Masaru Kanekiyo; Andrew Ward; Daniel Lingwood
Journal:  Immunity       Date:  2022-08-10       Impact factor: 43.474

2.  Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain.

Authors:  Leerang Yang; Matthew Van Beek; Zijun Wang; Frauke Muecksch; Marie Canis; Theodora Hatziioannou; Paul D Bieniasz; Michel C Nussenzweig; Arup K Chakraborty
Journal:  bioRxiv       Date:  2022-08-25

3.  Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses.

Authors:  Jared Feldman; Julia Bals; Clara G Altomare; Kerri St Denis; Evan C Lam; Blake M Hauser; Larance Ronsard; Maya Sangesland; Thalia Bracamonte Moreno; Vintus Okonkwo; Nathania Hartojo; Alejandro B Balazs; Goran Bajic; Daniel Lingwood; Aaron G Schmidt
Journal:  Sci Immunol       Date:  2021-12-10

4.  Viral surface geometry shapes influenza and coronavirus spike evolution through antibody pressure.

Authors:  Assaf Amitai
Journal:  PLoS Comput Biol       Date:  2021-12-13       Impact factor: 4.475

Review 5.  Protein engineering strategies for rational immunogen design.

Authors:  Timothy M Caradonna; Aaron G Schmidt
Journal:  NPJ Vaccines       Date:  2021-12-17       Impact factor: 7.344

6.  Increased B Cell Selection Stringency In Germinal Centers Can Explain Improved COVID-19 Vaccine Efficacies With Low Dose Prime or Delayed Boost.

Authors:  Amar K Garg; Soumya Mittal; Pranesh Padmanabhan; Rajat Desikan; Narendra M Dixit
Journal:  Front Immunol       Date:  2021-11-30       Impact factor: 7.561

Review 7.  Influenza immune escape under heterogeneous host immune histories.

Authors:  Rachel J Oidtman; Philip Arevalo; Qifang Bi; Lauren McGough; Christopher Joel Russo; Diana Vera Cruz; Marcos Costa Vieira; Katelyn M Gostic
Journal:  Trends Microbiol       Date:  2021-07-01       Impact factor: 17.079

Review 8.  An Antigenic Thrift-Based Approach to Influenza Vaccine Design.

Authors:  Jai S Bolton; Hannah Klim; Judith Wellens; Matthew Edmans; Uri Obolski; Craig P Thompson
Journal:  Vaccines (Basel)       Date:  2021-06-16

Review 9.  Antibody Focusing to Conserved Sites of Vulnerability: The Immunological Pathways for 'Universal' Influenza Vaccines.

Authors:  Maya Sangesland; Daniel Lingwood
Journal:  Vaccines (Basel)       Date:  2021-02-05

10.  Engineering an Antibody V Gene-Selective Vaccine.

Authors:  Larance Ronsard; Ashraf S Yousif; Julianne Peabody; Vintus Okonkwo; Pascal Devant; Alemu Tekewe Mogus; Ralston M Barnes; Daniel Rohrer; Nils Lonberg; David Peabody; Bryce Chackerian; Daniel Lingwood
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.